What is Mycapssa (tP Enhanced) and where does sodium caprylate fit in?
Mycapssa is the brand name for osimertinib using a tP (treatment/technology) enhanced release formulation, designed to help with oral absorption. The formulation includes sodium caprylate as part of the excipient system, which helps support drug dissolution/absorption in the gut for this product. [1]
What does “tP Enhanced” mean for Mycapssa?
The “tP” enhanced delivery system is used to improve how osimertinib is released and absorbed after you take the tablet. In Mycapssa, the excipient package includes sodium caprylate along with other formulation components to support that performance. [1]
What is sodium caprylate, and why is it used in drug products?
Sodium caprylate is a formulation excipient used to influence the microenvironment in which the drug dissolves, supporting consistent absorption. In Mycapssa, sodium caprylate is one of the excipients used to help achieve the product’s intended pharmacokinetic performance. [1]
Is sodium caprylate the only excipient in Mycapssa?
No. Mycapssa contains a full set of excipients, and sodium caprylate is one of them. The exact excipient list is provided in the product labeling or prescribing information. [1]
Where can I find the official excipient list for Mycapssa?
Look at the Mycapssa prescribing information (or the equivalent official label in your country). That document lists the excipients, including sodium caprylate, and explains the formulation approach. [1]
Sources
[1] https://www.ema.europa.eu/en/medicines/human/EPAR/mycapssa